Perego, G., Nozza, R., Oggionni, E., Cabiddu, M., Scolari, C., Omati, E., . . . Petrelli, F. (2020). Pharmacological issues concerning olaparib capsule and tablet formulations in treating ovarian cancer: Are they really the same drug? Journal of Oncology Pharmacy Practice, 26(4), 967. https://doi.org/10.1177/1078155219900913
Chicago Style (17th ed.) CitationPerego, Gianluca, Renata Nozza, Emanuela Oggionni, Mary Cabiddu, Cinzia Scolari, Elena Omati, Emanuela A. Castelli, and Fausto Petrelli. "Pharmacological Issues Concerning Olaparib Capsule and Tablet Formulations in Treating Ovarian Cancer: Are They Really the Same Drug?" Journal of Oncology Pharmacy Practice 26, no. 4 (2020): 967. https://doi.org/10.1177/1078155219900913.
MLA (9th ed.) CitationPerego, Gianluca, et al. "Pharmacological Issues Concerning Olaparib Capsule and Tablet Formulations in Treating Ovarian Cancer: Are They Really the Same Drug?" Journal of Oncology Pharmacy Practice, vol. 26, no. 4, 2020, p. 967, https://doi.org/10.1177/1078155219900913.